TCM
PFE icon

TT Capital Management’s Pfizer PFE Stock Holding History

TT Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Sell
27,855
-500
-2% -$13.1K 0.52% 42
2026
Q1 		$796K Sell
28,355
-1,150
-4% -$30.6K 0.66% 31
2025
Q4 		$735K Sell
29,505
-905
-3% -$22.8K 0.59% 32
2025
Q3 		$775K Sell
30,410
-3,050
-9% -$75.3K 0.59% 32
2025
Q2 		$811K Buy
33,460
+922
+3% +$21.5K 0.66% 29
2025
Q1 		$825K Buy
32,538
+5,725
+21% +$150K 0.69% 26
2024
Q4 		$710K Buy
+26,813
New +$727K 0.57% 33

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TT Capital Management's PFE Position: Q2 2026 in Review

TT Capital Management reduced its Pfizer (PFE) stake by 1.8% in Q2 2026, selling an estimated $13.1K and leaving 27,855 shares worth $671K. The position accounts for 0.52% of the portfolio, ranked #42.

TT Capital Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $825K in Q1 2025. 2,832 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • TT Capital Management held 27,855 shares of Pfizer worth $671K as of Q2 2026.
  • TT Capital Management sold 500 Pfizer shares in Q2 2026, an estimated $13.1K.
  • Pfizer made up 0.52% of TT Capital Management's portfolio in Q2 2026, its #42 holding.
  • TT Capital Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • TT Capital Management's Pfizer position peaked at $825K in Q1 2025.
  • 2,832 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on TT Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.